Feng Kent Y, Short Sarah A, Saeb Sohrab, Carroll Megan K, Olivier Christoph B, Simard Edgar P, Swope Susan, Williams Donna, Eckstrand Julie, Pagidipati Neha, Shah Svati H, Hernandez Adrian F, Mahaffey Kenneth W
Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Verily Life Sciences, South San Francisco, CA, United States.
J Med Internet Res. 2024 Dec 20;26:e60493. doi: 10.2196/60493.
Though widely used, resting heart rate (RHR), as measured by a wearable device, has not been previously evaluated in a large cohort against a variety of important baseline characteristics.
This study aimed to assess the validity of the RHR measured by a wearable device compared against the gold standard of ECG (electrocardiography), and assess the relationships between device-measured RHR and a broad range of clinical characteristics.
The Project Baseline Health Study (PHBS) captured detailed demographic, occupational, social, lifestyle, and clinical data to generate a deeply phenotyped cohort. We selected an analysis cohort within it, which included participants who had RHR determined by both ECG and the Verily Study Watch (VSW). We examined the correlation between these simultaneous RHR measures and assessed the relationship between VSW RHR and a range of baseline characteristics, including demographic, clinical, laboratory, and functional assessments.
From the overall PBHS cohort (N=2502), 875 (35%) participants entered the analysis cohort (mean age 50.9, SD 16.5 years; n=519, 59% female and n=356, 41% male). The mean and SD of VSW RHR was 66.6 (SD 11.2) beats per minute (bpm) for female participants and 64.4 (SD 12.3) bpm for male participants. There was excellent reliability between the two measures of RHR (ECG and VSW) with an intraclass correlation coefficient of 0.946. On univariate analyses, female and male participants had similar baseline characteristics that trended with higher VSW RHR: lack of health care insurance (both P<.05), higher BMI (both P<.001), higher C-reactive protein (both P<.001), presence of type 2 diabetes mellitus (both P<.001) and higher World Health Organization Disability Assessment Schedule (WHODAS) 2.0 score (both P<.001) were associated with higher RHR. On regression analyses, within each domain of baseline characteristics (demographics and socioeconomic status, medical conditions, vitals, physical function, laboratory assessments, and patient-reported outcomes), different characteristics were associated with VSW RHR in female and male participants.
RHR determined by the VSW had an excellent correlation with that determined by ECG. Participants with higher VSW RHR had similar trends in socioeconomic status, medical conditions, vitals, laboratory assessments, physical function, and patient-reported outcomes irrespective of sex. However, within each domain of baseline characteristics, different characteristics were most associated with VSW RHR in female and male participants.
ClinicalTrials.gov NCT03154346; https://clinicaltrials.gov/study/NCT03154346.
静息心率(RHR)虽被广泛应用,但此前尚未在大型队列中针对多种重要基线特征对可穿戴设备测量的静息心率进行评估。
本研究旨在评估可穿戴设备测量的静息心率与心电图(ECG)金标准相比的有效性,并评估设备测量的静息心率与广泛临床特征之间的关系。
基线健康项目研究(PHBS)收集了详细的人口统计学、职业、社会、生活方式和临床数据,以建立一个深度表型队列。我们在其中选择了一个分析队列,该队列包括通过心电图和Verily研究手表(VSW)测定静息心率的参与者。我们检查了这些同步静息心率测量值之间的相关性,并评估了VSW静息心率与一系列基线特征之间的关系,包括人口统计学、临床、实验室和功能评估。
在整个PHBS队列(N = 2502)中,875名(35%)参与者进入分析队列(平均年龄50.9岁,标准差16.5岁;n = 519,59%为女性,n = 356,41%为男性)。女性参与者VSW静息心率的平均值和标准差为每分钟66.6次(标准差11.2次),男性参与者为每分钟64.4次(标准差12.3次)。两种静息心率测量方法(心电图和VSW)之间具有出色的可靠性,组内相关系数为0.946。在单变量分析中,女性和男性参与者具有相似的基线特征,这些特征与较高的VSW静息心率相关:缺乏医疗保险(均P <.05)、较高的体重指数(均P <.001)、较高的C反应蛋白(均P <.001)、2型糖尿病的存在(均P <.001)以及较高的世界卫生组织残疾评估量表(WHODAS)2.0评分(均P <.001)与较高的静息心率相关。在回归分析中,在基线特征的每个领域(人口统计学和社会经济地位、医疗状况、生命体征、身体功能、实验室评估和患者报告的结果)中,不同特征与女性和男性参与者的VSW静息心率相关。
VSW测定的静息心率与心电图测定的静息心率具有出色的相关性。无论性别如何,VSW静息心率较高的参与者在社会经济地位、医疗状况、生命体征、实验室评估、身体功能和患者报告的结果方面具有相似的趋势。然而,在基线特征的每个领域中,不同特征与女性和男性参与者的VSW静息心率最为相关。
ClinicalTrials.gov NCT03154346;https://clinicaltrials.gov/study/NCT03154346。